Australia: Liquidators and the TGA – legislative and practical issues

Last Updated: 24 January 2017
Article by William Clement and Ian Currie

Liquidators can face significant issues when appointed over companies that operate under the licencing regime of the Therapeutic Goods Administration (TGA).

The TGA is a Commonwealth Government agency administered by the Department of Health. It's responsible for regulating the supply, import, export, manufacturing and advertising of therapeutic goods – which can range from biological products (like stem cells and cord blood) to medical devices (such as blood pressure monitors and MRI scanners).1 It also issues licences to companies that handle therapeutic goods.

The TGA operates in accordance with the Therapeutic Goods Act 1989 (Cth) (the Act) and the accompanying Therapeutic Goods Regulations 1990 (Cth) (the Regulations). The Act provides for controls relating to the quality, safety, efficacy and availability of therapeutic goods produced or used with Australia.2

Legislative issues for liquidators

The main concern for external administrators appointed over companies that deal in therapeutic goods is the potential exposure of personal liability.

Under the Regulations, the liquidator of a company holding a licence under the Act is deemed to be the holder of that licence.3 The same is true for trustees in bankruptcy of a bankrupt licence holder.4 The liquidator or trustee is also required to notify the TGA of their appointment within three months.5

Liquidators are always concerned about criminal or civil liabilities that may arise for misconduct that may have occurred before their appointment, or of which they are unaware. As with most appointments, liquidators generally have little or no knowledge of an insolvent company's previous practices.

This is particularly true in highly specialised industries (such as therapeutic goods), where a liquidator relies on directors' and employees' cooperation after appointment. Unfortunately, however, the Act provides for serious criminal and civil penalties against licence holders for acts or omissions that breach conditions of the licence.6

Liquidators should, therefore, exercise extreme caution when deciding whether to accept an appointment, to continue trading or to discuss the matter with key directors or employees. In fact, they should always consult with their insurance broker to ensure they're covered by an existing or new policy.

Practical issues – the case of StemTech

A liquidator's issues don't stop, however, just by ceasing to trade. They're still responsible for an insolvent company – one that's probably short of cash and unable to fund the short-term liabilities (such as rent, wages and supplier payments) that preserve the products covered by the TGA licence.

In a recent matter, BRI Ferrier Brisbane was appointed liquidator of StemTech Pty Ltd (StemTech) which harvested and stored cord blood from mothers after giving birth. The cord blood was processed and frozen by StemTech using liquid nitrogen (with any change in storage temperature potentially causing the blood to spoil).

Upon our appointment, StemTech had arrears in rent, electricity, liquid nitrogen, blood storage containers, couriers and other suppliers required for products or services to preserve and protect the integrity of the company's biological products. It also owed payments to key employees who were told they were out of a job and may have to wait months to receive their entitlements from the Federal Government.

Cooperation from these parties was even less likely once the liquidator explained there was no cash available until assets were sold and/or debtors collected (and the debtors may have refused to pay until guaranteed the integrity of their biological products).

Situations like these are not unusual to liquidators and are the reason the Corporations Act 2001 (Cth) includes provisions such as section 545 (which ensures a liquidator is not liable for expenses unless property is available to meet those costs) and section 568 (which allows a liquidator to disclaim property).

The bad news is that it's not clear how these provisions interact with those of the Therapeutic Goods Act. Common sense suggests that, if a liquidator with no funds is unable to reach a suitable agreement for the sale or transfer of a company's biological and therapeutic goods, he or she would be justified in disclaiming and surrendering the assets to the appropriate authorities.

In StemTech's case, while this approach may be justifiable, the therapeutic goods were stored by parents in the hope that the stem cells contained within the cord blood might be used to treat current or future diseases that inflict them or their children.

Public outcry would undoubtedly follow if a liquidator was identified as the person who allowed biological products to spoil by not personally funding essential preservation costs. Such controversy would bring adverse attention to the liquidator's practice and would, in turn, potentially trigger legal action by the TGA and by parents storing their child's cord blood.

The TGA has no fact sheets or guidance for liquidators in such situations. It's therefore prudent for liquidators to seek directions from the court before making decisions that affect the life of the biological products.

Sale and transfer issues

Even when a liquidator can negotiate deals with relevant parties and arrange a sale of the company's assets and/or the takeover of its business, their problems don't always immediately cease.

It's difficult to escape exposure to liability from pre- and post-liquidation practices. A liquidator is therefore well advised to write exhaustive 'exclusion of liability' clauses into sale agreements, with respect to the integrity of the biological products (even though such products may not be sold, as the company would have no title to them).

Also, if a business purchaser requires the removal and transport of storage facilities and biological products, the liquidator should seek to transfer the liability for related problems to the purchaser, and possible indemnification for losses that arise.

This transfer of cord blood products may require specialised equipment and be time-consuming. It should, therefore, be factored into sale agreements.

In addition, a liquidator should keep the TGA apprised of each step in writing.

In the matter of StemTech, we negotiated the sale of relevant assets to a competitor who was required to assume liability for holding costs. It was also required to accept responsibility, with the TGA's approval, for the specialised transport of assets housing the cord blood products to their interstate premises.

In negotiating the sale, the cord blood of over 2,000 children was preserved, adverse publicity to the therapeutic goods industry was averted, and potential further liabilities to StemTech and the liquidator were avoided.


1 Therapeutic Goods Act 1989 (Cth) s 3 (definition of 'therapeutic goods').

2 Ibid s 4(1).

3 Therapeutic Goods Regulations 1990 (Cth) s 22(3)(a).

4 Ibid s 22(2)(a).

5 Ibid ss 22(2)(b), 22(3)(b)

6 See, eg, Therapeutic Goods Act 1989 (Cth) ss 35B, 35C.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions